Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 are the main incretin hormones, and be responsible for the insulinotropic incretin effect. The addition of a GIP agonist to a GLP-1agonist has been hypothesized to significantly potentiate the weight-losing and glycemia control...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qian, Lei, Xingxing, Fu, Shunlian, Liu, Pan, Long, Cong, Wang, Yanmei, Li, Zinan, Xie, Qian, Chen, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614386/
https://www.ncbi.nlm.nih.gov/pubmed/37904255
http://dx.doi.org/10.1186/s13098-023-01198-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614386/
https://www.ncbi.nlm.nih.gov/pubmed/37904255
http://dx.doi.org/10.1186/s13098-023-01198-4

Ejemplares similares